- Home
- LNN vs TVTX Comparison
LNN vs TVTX Comparison
Compare LNN & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNN
- TVTX
- Stock Information
- Founded
- LNN 1954
- TVTX 2008
- Country
- LNN United States
- TVTX United States
- Employees
- LNN N/A
- TVTX N/A
- Industry
- LNN Industrial Machinery/Components
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- LNN Industrials
- TVTX Health Care
- Exchange
- LNN Nasdaq
- TVTX Nasdaq
- Market Cap
- LNN 1.5B
- TVTX 1.6B
- IPO Year
- LNN 1988
- TVTX N/A
- Fundamental
- Price
- LNN $123.21
- TVTX $17.37
- Analyst Decision
- LNN Buy
- TVTX Buy
- Analyst Count
- LNN 2
- TVTX 13
- Target Price
- LNN $132.00
- TVTX $23.46
- AVG Volume (30 Days)
- LNN 88.6K
- TVTX 1.4M
- Earning Date
- LNN 01-02-2025
- TVTX 02-13-2025
- Dividend Yield
- LNN 1.17%
- TVTX N/A
- EPS Growth
- LNN N/A
- TVTX N/A
- EPS
- LNN 6.01
- TVTX N/A
- Revenue
- LNN $607,074,000.00
- TVTX $203,447,000.00
- Revenue This Year
- LNN $10.09
- TVTX $62.17
- Revenue Next Year
- LNN $4.70
- TVTX $56.38
- P/E Ratio
- LNN $20.40
- TVTX N/A
- Revenue Growth
- LNN N/A
- TVTX 57.08
- 52 Week Low
- LNN $109.27
- TVTX $5.12
- 52 Week High
- LNN $135.20
- TVTX $20.33
- Technical
- Relative Strength Index (RSI)
- LNN 42.21
- TVTX 43.48
- Support Level
- LNN $121.78
- TVTX $16.66
- Resistance Level
- LNN $131.70
- TVTX $19.20
- Average True Range (ATR)
- LNN 3.27
- TVTX 0.74
- MACD
- LNN -1.16
- TVTX -0.24
- Stochastic Oscillator
- LNN 21.95
- TVTX 23.24
About LNN Lindsay Corporation
Lindsay Corp provides various proprietary water management and road infrastructure products and services. It has operations categorized into two main reporting segments: Irrigation, and Infrastructure. The company generates maximum revenue from the Irrigation segment. Its Irrigation segment includes manufacturing and marketing center pivot, lateral move, and hose reel irrigation systems, as well as various technology solutions such as GPS positioning and guidance, variable rate irrigation, wireless irrigation management, M2M communication technology, and smartphone applications. Geographically, it derives a majority of its revenue from the United States.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.